These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18093141)

  • 1. Active immunization of hamsters against Clostridium difficile infection using surface-layer protein.
    Ní Eidhin DB; O'Brien JB; McCabe MS; Athié-Morales V; Kelleher DP
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):207-18. PubMed ID: 18093141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive immunisation of hamsters against Clostridium difficile infection using antibodies to surface layer proteins.
    O'Brien JB; McCabe MS; Athié-Morales V; McDonald GS; Ní Eidhin DB; Kelleher DP
    FEMS Microbiol Lett; 2005 May; 246(2):199-205. PubMed ID: 15899406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human antibody response to surface layer proteins in Clostridium difficile infection.
    Drudy D; Calabi E; Kyne L; Sougioultzis S; Kelly E; Fairweather N; Kelly CP
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):237-42. PubMed ID: 15196573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile.
    Péchiné S; Janoir C; Boureau H; Gleizes A; Tsapis N; Hoys S; Fattal E; Collignon A
    Vaccine; 2007 May; 25(20):3946-54. PubMed ID: 17433506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile flagellin FliC: Evaluation as adjuvant and use in a mucosal vaccine against Clostridium difficile.
    Bruxelle JF; Mizrahi A; Hoÿs S; Collignon A; Janoir C; Péchiné S
    PLoS One; 2017; 12(11):e0187212. PubMed ID: 29176760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of hamsters against Clostridium difficile infection using the Cwp84 protease as an antigen.
    Péchiné S; Denève C; Le Monnier A; Hoys S; Janoir C; Collignon A
    FEMS Immunol Med Microbiol; 2011 Oct; 63(1):73-81. PubMed ID: 21707776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters.
    Giannasca PJ; Zhang ZX; Lei WD; Boden JA; Giel MA; Monath TP; Thomas WD
    Infect Immun; 1999 Feb; 67(2):527-38. PubMed ID: 9916055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of vaccine for Clostridium difficile infection using membrane fraction of nontoxigenic Clostridium difficile.
    Senoh M; Iwaki M; Yamamoto A; Kato H; Fukuda T; Shibayama K
    Microb Pathog; 2018 Oct; 123():42-46. PubMed ID: 29959036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models.
    Bruxelle JF; Mizrahi A; Hoys S; Collignon A; Janoir C; Péchiné S
    Anaerobe; 2016 Feb; 37():78-84. PubMed ID: 26505926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
    Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
    J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
    Hickey DK; Aldwell FE; Beagley KW
    Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
    Chaitra MG; Nayak R; Shaila MS
    Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile TxAC314 and SLP-36kDa enhance the immune response toward a co-administered antigen.
    Brun P; Scarpa M; Grillo A; Palù G; Mengoli C; Zecconi A; Spigaglia P; Mastrantonio P; Castagliuolo I
    J Med Microbiol; 2008 Jun; 57(Pt 6):725-731. PubMed ID: 18480329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active and passive immunization to protect against antibiotic associated caecitis in hamsters.
    Fernie DS; Thomson RO; Batty I; Walker PD
    Dev Biol Stand; 1983; 53():325-32. PubMed ID: 6873474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel fusion protein containing the receptor binding domains of C. difficile toxin A and toxin B elicits protective immunity against lethal toxin and spore challenge in preclinical efficacy models.
    Tian JH; Fuhrmann SR; Kluepfel-Stahl S; Carman RJ; Ellingsworth L; Flyer DC
    Vaccine; 2012 Jun; 30(28):4249-58. PubMed ID: 22537987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
    Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.
    Yang XQ; Zhao YG; Chen XQ; Jiang B; Sun DY
    BMC Gastroenterol; 2013 Jul; 13():117. PubMed ID: 23865596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and passive immunization against Clostridium difficile diarrhea and colitis.
    Giannasca PJ; Warny M
    Vaccine; 2004 Feb; 22(7):848-56. PubMed ID: 15040937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.